Optimal Timing of Vericiguat Therapy in Patients with Heart Failure with Reduced/Mildly Reduced Ejection Fraction for Improving Mortality and Heart Failure Re-Hospitalization Rate.

J Clin Med · 2025 · PMC12387012 · PMID 40869682

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = 0.14not close (p > 0.1)

Intergroup comparisons of parameter changes showed similar trends, though they did not reach statistical significance (BNP: p = 0.14; eGFR: p = 0.053; LVEF: p = 0.37; Figure 5 A–C). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.